Type IV phosphodiesterase inhibitor is effective in prevention and treatment of experimental crescentic glomerulonephritis

Nephron

Volumn 84, Issue 1, 2000, Pages 58-66

  Tam, Frederick W K ^a   Smith, Jennifer ^a   Agarwal, Sangita ^a   Karkar, Ayman M ^a   Morel, Delphine ^a   Thompson, Elizabeth M ^b   Pusey, Charles D ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

^b IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

Glomerular basement membrane; Glomerulonephritis; Phosphodiesterase inhibitor; Rolipram; Tumour necrosis factor alpha

Indexed keywords

ALBUMIN; FIBRIN; PHOSPHODIESTERASE INHIBITOR; PHOSPHODIESTERASE IV; ROLIPRAM; TOXIC SUBSTANCE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; DRUG EFFICACY; FIBRIN DEPOSITION; GLOMERULONEPHRITIS; GLOMERULUS; KIDNEY TUBULE; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEINURIA; RAT; URINARY EXCRETION;

EID: 0033964770     PISSN: 00282766     EISSN: None     Source Type: Journal    
DOI: 10.1159/000045539     Document Type: Article

References (37)

1. Egido J, Gomez Chiarri M, Ortiz A, Bustos C, Alonso J, Gomez Guerrero C, Gomez Garre D, Lopez Armada MJ, Plaza J, Gonzalez E: Role of tumor necrosis factor-alpha in the pathogenesis of glomerular diseases. Kidney Int Suppl 1993;39:59-64.
2. Baud L, Ardaillou R: Tumor necrosis factor alpha in glomerular injury. Kidney Int Suppl 1994;45:S32-S36.
3. Noronha IL, Kruger C, Andrassy K, Ritz E, Waldherr R: In situ production of TNF-alpha, IL-1 beta and IL-2R in ANCA-positive glomerulonephritis. Kidney Int 1993;43:682-692.
4. Yoshioka K, Takemura T, Murakami M, Okada M, Yagi K, Miyazato H, Matsushima K: In situ expression of cytokines in IgA nephritis. Kidney Int 1993;44:825-833.
5. Bertani T, Abbate M, Zoja C, Corna D, Perico N, Ghezzi P, Remuzzi G: Tumor necrosis factor induces glomerular damage in the rabbit. Am J Pathol 1989;134:419-430.
6. Tomosugi NI, Cashman SJ, Hay H, Pusey CD, Evans DJ, Shaw A, Rees AJ: Modulation of antibody-mediated glomerular injury in vivo by bacterial lipopolysaccharide, tumor necrosis factor, and IL-1. J Immunol 1989;142:3083-3090.
7. Karkar AM, Tam FWK, Proudfoot A, Meager A, Rees AJ: Modulation of antibody-mediated glomerular injury in vivo by interleukin-6. Kidney Int 1993;44:967-973.
8. Karkar AM, Koshino Y, Cashman SJ, Dash AC, Bonnefoy J, Meager A, Rees AJ: Passive immunization against tumour necrosis factor-alpha (TNF-α) and IL-1 β protects from LPS enhancing glomerular injury in nephrotoxic nephritis in rats. Clin Exp Immunol 1992;90: 312-318.
9. Hruby ZW, Shirota K, Jothy S, Lowry RP: Antiserum against tumor necrosis factor-alpha and a protease inhibitor reduce immune glomerular injury. Kidney Int 1992;40:43-51.
10. Karkar AM Tam FWK, Steinkasserer A, Kurrle R, Langner K, Scallon BJ, Meager A, Rees AJ: Modulation of antibody-mediated glomerular injury in vivo by IL-1ra, soluble IL-1 receptor and soluble TNF receptor. Kidney Int 1995,48:1738-1746.
11. Tam FWK, Karkar AM, Smith J, Yoshimura T, Steinkasserer A, Kurrle R, Langner K, Rees AJ: Differenlial expression of macrophages inflammatory protein-2 and monocyte chemoattractant protein-1 in experimental glomerulonephritis. Kidney Int 1996;49:715-721.
12. Karkar AM, Smith J, Pusey CD: Treatment of established nephrotoxic nephritis by neutralization of TNF-alpha (abstract). J Am Soc Nephrol 1998;9:478.
13. Lee JC, Prabhakar U, Griswold DE, Dunnington D, Young PR, Badger A: Low-molecular-weight TNF biosynthesis inhibitors: Strategies and prospectives. Circ Shock 1995;44:97-103.
14. Prabhakar U, Lipshutz D, Bartus JO, Slivjak MJ, Smith EFI, Lee JC, Esser KM: Characterization of cAMP-dependent inhibition of LPS-induced TNFα production by rolipram, a specific phosphodiesterase IV (PDE IV) inhibitor. Int J Immunopharmacol 1994;16:805-816.
15. Ahn H-S, Foster M, Arik L, Boykow G, Foster C: Cyclic nucleotide phosphodiesterase isoenzymes in rat mesangial cells. Eur J Pharmacol 1995;289:49-57.
16. Rassier ME, McIntyre SJ, Yamaki M, Takeda S, Lin J-T, Dousa TP: Isoenzymes of cyclic-3′,5′-nucleotide phosphodiesterase in renal epithelial LLC-PK1 cells. Kidney Int 1992;41:88-99.
17. Dousa TP: Cyclic-3′,5′-nucleotide phosphodiesterase isoenzymes in cell biology and pathophysiology of the kidney. Kidney Int 1995;55:29-62.
18. Genain CP, Roberts T, Davis RL, Nguyen M-H, Uecelli A, Fauld D, Hedgpeth J, Hauser SL: Prevention of autoimmune demyelination in non-human primates by a cAMP specific phosphodiesterase inhibitor. Proc Natl Acad Sci USA 1995;92:3601-3605.
19. Sommer N, Loschmann P-A, Northoff GH, Weller M, Steinbrecher A, Steinbach JP, Lichtenfels R, Meyermann R, Riethmuller A, Fontana A, Dichgans J, Martin R: The antidepressant rolipram suppresses cytokine production and prevents autoimmune encephalomyelitis. Nat Med 1995;1:244-248.
20. Sekut L, Yarnall D, Stimpson SA, Noel LS, Bateman-Fite R, Clark RL, Brackeen MF, Menius JA Jr, Connolly KM: Anti-inflammatory activity of phosphodiesterase (PDE)-IV inhibitors in acute and chronic models of inflammation. Clin Exp Immunol 1995;100:126-132.
21. Tsuoboi Y, Shankland SJ, Grande JP, Walker HJ, Johnson RJ, Dousa TP: Suppression of mesangial proliferative glomerulonephritis development in rats by inhibitors of cAMP phosphodiesterase isoenzymes type III and IV. J Clin Invest 1996;98:262-270.
22. Kawasaki K, Yaoita E, Yamamoto T, Kihara I: Depletion of CD8 positive cells in nephrotoxic serum nephritis of WKY rats. Kidney Int 1992; 41:1517-1526.
23. Tam FWK, Smith J, Morel D, Karkar AM, Thompson EM, Cook HT, Pusey CD: Development of scarring and renal failure in a rat model of crescentic glomerulonephritis. Nephrol Dial Transplant 1999;14:1658-1666.
24. Bhan AK, Schneeberger EE, Collins AB, McCluskey RT: Evidence for a pathogenic role of a cell-mediated immune mechanism in experimental glomerulonephritis. J Exp Med 1978;148:246-260.
25. Cook HT, Cattell V, Smith J, Salmon JA, Moncada S: Effects of a thromboxane synthetase inhibitor on eicosanoid synthesis and glomerular injury during acute unilateral glomerulonephritis in the rat. Clin Nephrol 1986;26:195-199.
26. Tam FWK, Smith J, Cashman SJ, Wang Y, Thompson EM, Rees AJ: Glomerular expression of interleukin-1 receptor antagonist and interleukin-1β genes in antibody-mediated glomerulonephritis. Am J Pathol 1994;145:126-136.
27. Nagano T, Kita T, Tanaka N: The immunocytochemical localisation of tumour necrosis factor and leukotriene in the rat liver after treatment with lipopolysaccharide. Int J Exp Pathol 1992;73:675-683.
28. Meager A, Leung H, Woolley J: Assays for tumour necrosis factor and related cytokines. J Immunol Methods 1989;116:1-17.
29. Chini CCS, Chini EN, Williams JM, Matousovic K, Dousa TP: Formation of reactive oxygen metabolites in glomeruli is suppressed by inhibition of cAMP phosphodiesterase isozyme type IV. Kidney Int 1994;46:28-36.
30. Begany CP, Carcillo JA, Herzer WA, Mi Z, Jackson EK: Inhibition of type IV phosphodiesterase by Ro 20-1724 attenuates endotoxin-induced acute renal failure. J Pharmacol Exp Ther 1996;278:37-41.
31. Neale TJ, Ruger BM, Macaulay H, Dunbar PR, Hasan Q, BourkE A, Murray-McIntosh RP, Kitching AR: Tumour necrosis factor-α is expressed by glomErular visceral epithelial cells in human membranous nephropaThy. Am J Pathol 1995;146:1444-1454.
32. Jevnikar AM, Brennan DC, Singer GG, Heng JE, Maslinski W, Wuthrich RP, Glimcher LH, Rubin Kelley VE: Stimulated kidney tubular cells express membrane associated and secreted TNF-α. Kidney Int 1991;40:203-211.
33. Gearing AJ, Beckett P, Christodoulou M, Churchill M, Clements J, Davidson AH, Drummond AH, Galloway WA, Gilbert R, Gordon JL, Leber TM, Mangan M, Miller K, Nayee P, Owen K, Patel S, Thomas W, Wells G, Wood LM, Woolley K: Processing of tumour necrosis factor-alpha precursor by metalloproteinases. Nature 1994;370:555-557.
34. McGeehan GM, Becherer JD, Bast RCJ, Boyer CM, Champion B, Connolly KM, Conway JG, Furdon P, Karp S, Kidao S, McElroy AB, Nichols J, Pryzwansky KM, Schoenen F, Sekut L, Truesdale A, Verghese M, Warner J, Ways JP: Regulation of tumour necrosis factor-alpha processing by a metalloproteinase inhibitor. Nature 1994;370:558-561.
35. Breyer MD, Zhang YH, Guan Y-F, Hao C-M, Hebert R-L, Breyer RM: Regulation of renal function by prostaglandin E receptors. Kidney Int 1998;54(suppl67):88-94.
36. Wada T, Yokoyama H, Furuichi K, Kobayashi K-I, Harada K, Naruto M, Su S-B, Akiyama M, Mukaida N, Matsushima K: Intervention of crescentic glomerulonephritis by antibodies to monocyte chemotactic and activating factor (MCAF/MCP-1). FASEB J 1996;10:1418-1425.
37. Kawasaki K, Yaoita E, Yamamoto T, Tamatani T, Miyasaka M, Kihara I: Antibodies against intercellular adhesion molecule-1 and lymphocyte function-associated antigen-1 prevent glomerular injury in rat experimental crescentic glomerulonephritis. J Immunol 1993;150:1074-1083.